Evidence map›Paper›PMID 42760961›Full record

ArticleFrontiers in medicine2026

Associations of tear mediators with ocular surface symptoms, signs, and corneal nerve morphology in dry eye disease: a cross-sectional study.

Lijin Cui, Ruixuan Jia, Chenyue Yu, Zhaoxiang Xu, Yao Yao, Jian Guo, Xiaotong Ren

Abstract read
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lijin Cui *Department of Ophthalmology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China.
Ruixuan Jia *Department of Ophthalmology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China.
Chenyue Yu *Department of Ophthalmology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China.
Zhaoxiang XuNanping Wuyi Housheng Eye Hospital, Nanping, China.
Yao YaoDepartment of Ophthalmology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China.
Jian GuoDepartment of Ophthalmology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China.
Xiaotong RenDepartment of Ophthalmology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To investigate associations between tear mediators and ocular symptoms, signs, and corneal nerve parameters in patients with dry eye disease (DED). Methods: This cross-sectional study included 101 DED patients. Six tear mediators (IL-6, NGF, SP, CGRP, MMP-9, β-endorphin) were measured by Luminex. Symptoms (10-item questionnaire and OSDI), signs (TMH, TBUT, CFS), and corneal subbasal nerve parameters were assessed. Spearman's correlation was used. For eye-specific parameters, values from both eyes were averaged to obtain patient-level measurements. Results: β-Endorphin showed a strong negative correlation with ocular pain ( Conclusion: Tear β-endorphin is uniquely associated with less pain and better corneal nerve preservation. Microneuromas link to pro-inflammatory mediators. Tear mediators reflect ocular surface damage (CFS) but not tear quantity and stability, suggesting that tear mediators profiling may reflect inflammatory and neuropathic mechanisms in DED, warranting further validation in controlled studies.

Indexed as

corneal nervesdry eye disease (DED)microneuromaMMP-9tear mediatorsβ-endorphin

Identifiers

PMID42760961
PMCPMC13585605

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.